The 12th annual report of the North American Pediatric Renal Transplant Cooperative Study: Renal transplantation from 1987 through 1998

Pediatric Transplantation

Volumn 5, Issue 3, 2001, Pages 215-231

  Seikaly, Mouin ^a   Ho, P L ^b   Emmett, Lea ^c   Tejani, Amir ^c,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b EMMES CORPORATION   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d NAPRTCS   (United States)

Author keywords

Cadaver donor; Living donor; Pediatric transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CADAVER DONOR; CAUCASIAN; CHILD; CHILD GROWTH; DISEASE COURSE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; NEWBORN; NORTH AMERICA; SURVIVAL;

EID: 0034970802     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1397-3142.2001.00001.x     Document Type: Article

References (35)

1. The 1989 report of the North American Pediatric Renal Transplant Cooperative Study
2. Cyclosporin A mediates immunosuppression of primary cytotoxic T-cell responses by impairing the release of interleukin 1 and interleukin 2
3. Effect of cyclosporin A on T-cell function in vitro: The mechanism of suppression of T-cell proliferation depends on the nature of the T-cell stimulus as well as the differentiation state of the responding T cell
4. Maintenance immunosuppression therapy and outcome of renal transplantation in North American children - A report of the North American Pediatric Renal Transplant Cooperative Study
5. Do six-antigen matched cadaver donor kidneys provide better graft survival to children compared to one-haploidentical living-related donor transplants?: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
6. Pre-transplant blood transfusion and renal allograft outcome: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
7. Steady improvement in renal allograft survival among North American children. A five-year appraisal by the North American Pediatric Renal Transplant Cooperative Study
8. Safety of kidney biopsy in pediatric transplantation: A report of the Controlled Clinical Trials in Pediatric Transplantation (CCTPT) trial of induction therapy study group
9. Analysis of rejection outcomes and implications. A report of the North American Pediatric Renal Transplant Cooperative Study
10. A decade of living donor transplantation in North American children. The 1998 Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
11. Demographics, Immunotherapy and Outcome of Pediatric Renal Transplants in North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
12. Renal transplantation in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
13. A randomized prospective, multicenter trial of T-cell antibody induction therapy in pediatric transplantation
14. Risk factors for post-transplant lymphoproliferative disorder (PTLD) in pediatric kidney transplants: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
15. Acute rejection rate, time to first rejection and rejection reversals comparing a 1987-89 pediatric renal transplant recipient cohort to a 1997-99 cohort
16. Clinical correlates of chronic rejection in pediatric renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
17. The impact of acute rejection on chronic rejection: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
18. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
19. Sirolimus reverses the progression of graft vascular disease in aortic allografts
20. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase
21. Interleukin-2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin
22. Rapamycin-FKBP specifically blocks growth-dependent activation of, and signaling by, the 70 Kd S6 kinase
23. Factors predictive of sustained growth in children post-transplantation
24. Long-term follow-up of growth in children post-transplantation
25. A longitudinal study of the natural history of growth post-transplantation
26. Alternate day steroid dosing improves growth without adversely affecting graft survival or long-term graft function: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
27. Center volume effects in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study
28. Glucocorticoids and growth problems
29. Cortisol decreases bone formation by inhibiting periosteal cell proliferation
30. The effects of different steroids on costal and epiphyseal cartilage of foetal and adult rats
31. Prednisone inhibits the efficacy of recombinant human growth hormone in pediatric renal recipients
32. Catch-up growth in children with successful renal transplants immunosuppressed with CsA alone
33. Follow-up of cyclosporine-treated pediatric renal allograft recipients after cessation of prednisone
34. Strategies for optimizing growth in children with kidney transplants